rts logo

Hepion Pharmaceuticals Inc (HEPA) Is Down -65.50% in 2025 With Lots of Room to Run

Hepion Pharmaceuticals Inc (NASDAQ: HEPA) is -65.50% lower on its value in year-to-date trading and has touched a low of $0.12 and a high of $3.49 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HEPA stock was last observed hovering at around $0.18 in the last trading session, with the day’s loss setting it -0.02%.

Currently trading at $0.16, the stock is -55.08% and -67.23% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 8.46 million and changing -9.64% at the moment leaves the stock -80.09% off its SMA200. HEPA registered -91.46% loss for a year compared to 6-month loss of -79.01%. The firm has a 50-day simple moving average (SMA 50) of $0.50556 and a 200-day simple moving average (SMA200) of $0.82416.

The stock witnessed a -65.50% gain in the last 1 month and extending the period to 3 months gives it a -75.68%, and is -1.70% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 22.83% over the week and 23.90% over the month.

Hepion Pharmaceuticals Inc (HEPA) has around 22 employees, a market worth around $1.73M and $0.00M in sales. Distance from 52-week low is 34.05% and -95.35% from its 52-week high.

.

Hepion Pharmaceuticals Inc (HEPA) Top Institutional Holders

27.0 institutions hold shares in Hepion Pharmaceuticals Inc (HEPA), with institutional investors hold 7.85% of the company’s shares. The shares outstanding are 10.62M, and float is at 10.61M with Short Float at 1.99%. Institutions hold 7.85% of the Float.

Hepion Pharmaceuticals Inc (HEPA) Insider Activity

#####

Related Posts